Offer - Urjas Oil for just ₹ 1 X
Solubin C Eye Drop is a prescription drug, available for use as Drops. The alternative uses of Solubin C Eye Drop have also been explained below.
The right dosage of Solubin C Eye Drop depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Solubin C Eye Drop include Skin Rash. Some other side effects of Solubin C Eye Drop have been listed ahead. Normally, these side effects of Solubin C Eye Drop are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Solubin C Eye Drop has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Solubin C Eye Drop's effects on the liver, heart and kidney, if any, have been listed below.
Solubin C Eye Drop is contraindicated in people with pre-existing medical conditions like Liver Disease, Scleroderma, Tuberculosis (TB) as it can result in adverse effects. Other conditions have been mentioned below in the Solubin C Eye Drop contraindications section.
Drug reaction of Solubin C Eye Drop with other medicines has been reported. See below for a complete list.
You should also be aware that Solubin C Eye Drop is safe while driving, and is addiction.
Solubin C Eye Drop is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Solubin C Eye Drop safe for pregnant women?
Solubin C can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Solubin C Eye Drop safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Solubin C. So it is adviced to consult the doctor before using it.
What is the effect of Solubin C Eye Drop on the Kidneys?
Solubin C may have mild side effects on the kidneys.
What is the effect of Solubin C Eye Drop on the Liver?
There may be an adverse effect on the liver after taking Solubin C. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Solubin C Eye Drop on the Heart?
Solubin C can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Solubin C Eye Drop unless your doctor advises you to do so -
Is this Solubin C Eye Drop habit forming or addictive?
No, you will not get addicted to Solubin C Eye Drop.
Interaction between Food and Solubin C Eye Drop
Eating certain foods may increase the time it takes Solubin C Eye Drop to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Solubin C Eye Drop
Due to lack of research, there is no information about the side effects of taking Solubin C Eye Drop with alcohol.
Solubin C works by suppressing the body's normal immune response to inflammation which is responsible for symptoms such as swelling, redness, and itching. This results in decreased inflammation and provides relief from the symptoms associated with it.
Yes, Solubin C is used in the treatment of gastritis. It is presumed that Solubin C works in gastritis by suppressing the immune response which causes inflammation and additionally relieving the symptoms of gastritis such as stomach pain, stomach inflammation, and acid reflux.
No, Solubin C is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take this medicine without a doctor's recommendation because Solubin C suppresses the immune system which lowers the immunity that can lead to infection to the patient. Hence patient should seek doctors advice before taking this medication by himself.
Yes, long-term use of Solubin C may cause low potassium level in your body by increasing the excretion of potassium in the urine. This can result in symptoms such as muscle cramps, weakness, tiredness, and an irregular heartbeat.
Yes, Solubin C is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed at therapeutic doses such as fluid retention (swelling in your hands or ankles), increased appetite, increased sweating, and stomach upset. Do not hesitate to inform your doctor if you are facing any of the above.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Chloromycetin sodium succinate (chaloramphenicol sodium succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 739-742